There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

ScienceOpen disciplines: Medicine, Respiratory medicine

Comments

Comment on this article

Cited by 1

Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies
Authors: Richard ZuWallack, Lisa M Allen, Gemzel Hernandez …

See all cited by

The 24-h FEV1 time profile of olodaterol QD delivered via Respimat® in COPD: Results from two 6-week studies

Read this article at

Related collections

Inflamed lung in vitro co-culture models

Comments

Comment on this article

Similar content 2,467

Cited by 1